pubmed-article:12533095 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12533095 | lifeskim:mentions | umls-concept:C0027769 | lld:lifeskim |
pubmed-article:12533095 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:12533095 | lifeskim:mentions | umls-concept:C0752125 | lld:lifeskim |
pubmed-article:12533095 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:12533095 | lifeskim:mentions | umls-concept:C1704222 | lld:lifeskim |
pubmed-article:12533095 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
pubmed-article:12533095 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:12533095 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12533095 | pubmed:dateCreated | 2003-1-20 | lld:pubmed |
pubmed-article:12533095 | pubmed:abstractText | Polyglutamine-mediated neurodegeneration in spinocerebellar ataxia type 7 (SCA7) involves specific central nervous system structures despite widespread expression of the mutant ataxin-7 protein. | lld:pubmed |
pubmed-article:12533095 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12533095 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12533095 | pubmed:language | eng | lld:pubmed |
pubmed-article:12533095 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12533095 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12533095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12533095 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12533095 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12533095 | pubmed:month | Jan | lld:pubmed |
pubmed-article:12533095 | pubmed:issn | 0003-9942 | lld:pubmed |
pubmed-article:12533095 | pubmed:author | pubmed-author:FuYing-HuiYH | lld:pubmed |
pubmed-article:12533095 | pubmed:author | pubmed-author:TownsendJeann... | lld:pubmed |
pubmed-article:12533095 | pubmed:author | pubmed-author:EinumDavid... | lld:pubmed |
pubmed-article:12533095 | pubmed:author | pubmed-author:PtacekLouis... | lld:pubmed |
pubmed-article:12533095 | pubmed:author | pubmed-author:ClarkAnna MAM | lld:pubmed |
pubmed-article:12533095 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12533095 | pubmed:volume | 60 | lld:pubmed |
pubmed-article:12533095 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12533095 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12533095 | pubmed:pagination | 97-103 | lld:pubmed |
pubmed-article:12533095 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:12533095 | pubmed:meshHeading | pubmed-meshheading:12533095... | lld:pubmed |
pubmed-article:12533095 | pubmed:meshHeading | pubmed-meshheading:12533095... | lld:pubmed |
pubmed-article:12533095 | pubmed:meshHeading | pubmed-meshheading:12533095... | lld:pubmed |
pubmed-article:12533095 | pubmed:meshHeading | pubmed-meshheading:12533095... | lld:pubmed |
pubmed-article:12533095 | pubmed:meshHeading | pubmed-meshheading:12533095... | lld:pubmed |
pubmed-article:12533095 | pubmed:meshHeading | pubmed-meshheading:12533095... | lld:pubmed |
pubmed-article:12533095 | pubmed:meshHeading | pubmed-meshheading:12533095... | lld:pubmed |
pubmed-article:12533095 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12533095 | pubmed:articleTitle | A novel central nervous system-enriched spinocerebellar ataxia type 7 gene product. | lld:pubmed |
pubmed-article:12533095 | pubmed:affiliation | Department of Human Genetics, University of Utah, Salt Lake City, USA. | lld:pubmed |
pubmed-article:12533095 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12533095 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:12533095 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:6314 | entrezgene:pubmed | pubmed-article:12533095 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12533095 | lld:entrezgene |